Rockville, MD (Jan. 8)—The US Food and Drug Administration approved 69 new drug applications (NDAs) last year, the second lowest number of approvals in the past decade, according to the Jan. 15 edition of Drug Industry Daily. The data, analyzed by the Friedman, Billings, Ramsey Group (FBR), show that the number of NDAs fell 26% from 93 approvals in 2006, and is 17% below the 10-year average of 83.4.

Link to Article

Pharmaceutical Technology, Advanstar Communications Inc.